Vancouver, BC – TheNewswire – 21st Decemberst, 2020 – Solarvest BioEnergy Inc. (“Solarvest” or the “Company”) (TSXV: SVS), Solarvest through its wholly-owned subsidiary EverseaTM is pleased to announce plans to launch its organic omega-3 gum fruit drops for children after the year-end vacation break. The fruit drop was produced by our German contract manufacturer under high standards and subjected to quality control. In the final phase, the quality of the product is confirmed after the ongoing logistics for shipping and packaging. The company’s first of its kind gum nutritional product will be an exceptional competitor in the large and rapidly growing gum supplement market. The organic gum contains Solarvest’s proprietary, certified organic omega-3 DHA powder, a sustainable plant-based powder developed for organic, vegetarian and vegan consumers.
The company is actively working to add unique products to meet the demand for high quality organic, omega-3 and herbal health products. This first featured product will soon be on sale in the United States and will be available on the company’s e-commerce website (www.eversea.ca) and via Amazon. Eversea will be able to provide organic retailers with our branded products based on our patented ingredient (differentiation) so that they can benefit from the huge market demand for the product’s unique properties, especially for organic and vegan nutrition.
The company also announced the completion of its U.S. order fulfillment infrastructure and logistics system. Our west coast distribution point is close to the most important and important market for organic and plant-based nutritional supplements / foods. In addition, this strategic location is close to organic food processors, sustainable consumers and the organic baby food market. The system can be sold nationwide.
Eversea Omega-3 powder is USDA and EU organic certified and is manufactured using the company’s sustainable, proprietary process. Gerri Greenham, CEO, explains, “Our omega-3s are sustainable as they are expressed in algae and grown in controlled facilities so that marine species no longer have to be harvested. Our technology produces an organically certified, highly bioavailable long-chain omega-3 that cannot be produced by common plant species such as flaxseed or hemp that only contain ALA omega-3. Our customers buy a product to improve their health and therefore want an organic product with a clean label on the ingredients. “The company also intends to sell the powder supplement to organic food processors and marketers such as baby food suppliers to facilitate the development of improved proprietary products. The company also intends to pursue other premium pet health uses such as high omega-3 eggs, pet supplements, and food. “
Eversea has also initiated a second product run with its Germany-based, certified organic manufacturer in order to supplement domestic stocks and initiate international sales. Given that Eversea’s organic certified product has a competitive advantage with several differentiators focusing on sustainability, environmental protection, bioavailability and purity, the company will be able to find alternatives for the adult, senior, and infant formula markets To offer motherhood to complement its offer for young people.
“The market size for EPA and DHA finished omega-3 products reached $ 44.2 billion in 2019, according to the 2020 Global EPA & DHA Finished Goods Report. Market dynamics and new product development are driving increased growth in certain product categories and in several regions of the world, driving the global EPA and DHA consumer products market to a projected annual growth rate of 6.1% for 2020-2021. “
“The global gummy vitamins market size is estimated at $ 5.9 billion in 2020 and estimated at $ 10.6 billion by 2025, which is a CAGR of 12.5% in terms of value,” according to Reportlinker given on October 27, 2020 PRNewswirepress publication.
Solarvest BioEnergy Inc. is an algae biologics company whose manufacturing platform provides it with an extremely flexible system capable of manufacturing a wide range of products from omega-3 fatty acids to human therapeutic proteins. The company has successfully demonstrated the expression of BMP, a high quality therapeutic protein, viral antigens (immune stimulating proteins) and cecropins (antimicrobial peptide / protein). The company has initiated a program to express CBD and THC to be produced in GMP fermentation facilities.
For more information please contact:
Neither the TSX Venture Exchange nor its regulator (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
The statements made in this press release may contain forward-looking statements that involve a number of risks and uncertainties. Actual events or results could differ materially from the company’s expectations and forecasts.